Yoshiyuki Yamashita, MD, PhD1; Serge Sicouri, MD, PhD1; Gianluca Torregrossa, MD2; William A. Gray, MD3; Francis P. Sutter, DO2; Basel Ramlawi, MD1,2
Yoshiyuki Yamashita, MD, PhD1; Serge ...
This study aims to fill a literature gap by detailing outcomes of patients undergoing this novel approach for the treatment of both coronary artery and aortic valve disease.
This study aims to fill a literature gap by detailing outcomes of patients undergoing this novel approach for the treatment of both coronary artery and aortic valve disease.
Sabrina Nolan1,2; Kristian B. Filion, PhD1,2,3,4; Renee Atallah, MSc1; Emmanuel Moss, MD, MSc2,5; Pauline Reynier, MSc1; Mark J. Eisenberg, MD, MPH1,2,3,6
Sabrina Nolan1,2; Kristian B. Filion...
Hybrid coronary revascularization (HCR) has emerged as a potential alternative to surgery. We conducted a systematic review and meta-analysis of 9 cohort studies and 1 randomized controlled trial to compare HCR with CABG interventions.
Hybrid coronary revascularization (HCR) has emerged as a potential alternative to surgery. We conducted a systematic review and meta-analysis of 9 cohort studies and 1 randomized controlled trial to compare HCR with CABG interventions.